Compare F.N.B. Corporation Common Stock (FNB) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
F.N.B. Corporation Common Stock vs Altria Group Inc — how do they compare? F.N.B. Corporation Common Stock trades at $16.91 (market cap $6.07B), while Altria Group Inc trades at $73.24 (market cap $119.49B). The key difference: Altria Group Inc is far larger — about 19.7× F.N.B. Corporation Common Stock's market cap, and Altria Group Inc pays the higher dividend (6.2%). Which is the better fit depends on your goals — on Pluang, investors hold F.N.B. Corporation Common Stock for 0 Days and Altria Group Inc for 155 Days on average.
| FNB | MO | |
|---|---|---|
Market Cap | $6.07B | $119.49B |
Volume | 5,600,609 | 6,945,035 |
Sector | Financials | Consumer Staples |
52-Week High | $19.49 | $74.92 |
52-Week Low | $14.65 | $54.72 |
Typical Hold Time | 0 Days | 155 Days |
Enterprise Value | $10.61B | $141.70B |
Dividend Yield | 3.05% | 6.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNB trades at $17.05, down 0.76% on the day, with a neutral technical signal. The stock shows solid fundamentals with a P/E of 10.15 and P/B of 0.89, indicating potential undervaluation. Recent earnings have been mixed, with Q2 2026 beating estimates but Q1 missing. Revenue remains stable at $1.77 billion for 2025, with a strong net income margin of 33.04%. Analyst sentiment is positive, with 13 buy ratings and a consensus price target of $20.80.
The outlook for FNB is cautiously optimistic, supported by strong profitability and a favorable analyst consensus. Key opportunities include potential upside to the price target and consistent dividend payments. Risks involve earnings volatility, as seen in recent quarters, and competitive pressures in the banking sector. Investors should weigh the attractive valuation against execution risks and market conditions.
Altria Group (MO) trades at $73.16, up 2.09% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains strong profitability with 39% net income margin and generates robust operating cash flow of $9.3B. Recent earnings show alternating beats and misses, while analyst consensus remains positive with 61.5% buy ratings despite negative shareholder equity of -$2.24B.
MO offers a high dividend yield but faces structural challenges including declining cigarette volumes and regulatory uncertainty. The stock trades below analyst consensus target of $69.71, suggesting limited upside. Key risks include negative equity, margin compression, and dependence on declining tobacco products despite smoke-free initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About F.N.B. Corporation Common Stock
F.N.B. Corporation is a diversified financial services holding company headquartered in Pittsburgh, Pennsylvania, operating through its lead subsidiary, First National Bank of Pennsylvania. It provides commercial banking, consumer banking, wealth management, and insurance through more than 350 banking offices across seven states and Washington, D.C.
Read more on FNB →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
